Best Life Sciences Companies in Aarhus, Denmark
The 31 best Life Sciences companies in Aarhus, Denmark in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: NMD Pharma.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Aarhus
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Affinicon Antibody-drug conjugate technology platform for targeted delivery of known drugs to macrophages. | — | — | 3 | Jonas Heilskov Graversen CEO | Deadpooled | — | — |
| 2 | aros applied biotechnology AROS Applied Biotechnology is one of the providers of genomic services for the pharma industry and… | — | — | 32 | — | Acquired | 9 patents Cancer diagnostic biomarkers using DNA methylation and gene expression profiling | — |
| 3 | CLC bio Provider of bioinformatics analysis solutions | — | — | 68 | Thomas Knudsen Founder & Ex-CEO | Acquired | — | — |
| 4 | Dentosolve Manufacturer of calcium silicate-based dental cements for restorative dental procedures | — | — | 1 | — | Funding Raised | 4 patents Dental biomaterials: mineral trioxide aggregate for endodontic repair and root canal sealing | — |
| 5 | Ergasta Developer of liquid handling tools for research labs | — | — | — | Muwan Chen Co-Founder | Funding Raised | — | — |
| 6 | Esgaard Provider of smart devices for healing skin wounds | — | — | — | Mads Holbech Esmann Co-Founder | Unfunded | — | — |
| 7 | Guldmann Provider of equipment for physically disabled patients | — | — | 191 191 → 309 (+62%) | — | Unfunded | 105 patents Medical lifting and gait training equipment: straps, protective sleeves, hoist accessories. | — |
| 8 | Meta-IQ Developing novel drugs for the treatment of brain diseases like Multiple Sclerosis | — | — | — | Jette Nieland Co-Founder | Unfunded | — | — |
Top 12 Life Sciences companies in Aarhus
#1
Seed · Aarhus, Capital Region of Denmark · founded 2021 · 8 employees$17.2Mraised▾
Developer of immunotherapies for the treatment of a variety of cancers. The company combines expertise in antibody development and complement research to refine the BiCE technology and creates a new type of immunotherapy for the treatment of a variety of cancers.
- Jan 2025Seed$5.8M
- May 2024Seed$17.2M
#2
Series B · Aarhus, Capital Region of Denmark · founded 2015 · 26 employees$174.3Mraised▾
NMD Pharma is developing small molecule drugs for neuromuscular disorders including myasthenia gravis, amyotrophic lateral sclerosis, and spinal muscular atrophy (SMA). It is currently developing compounds that can maximize the residual muscle activity by targeting an ion channel specific to skeletal muscle fibers.
- Nov 2023Series B$80.8M
- Feb 2022Series B$39.6M
- Mar 2018Series A$47M
- Jun 2016Seed$6.9M
#3
Funding Raised · Aarhus, Capital Region of Denmark · founded 2009$1.6Mraised▾
Provider of a medical device for the treatment of migraine. The company offers Rehaler medical device is a drug-free inhaler based on accurately adjusted partial rebreathing, used during the aura phase of a migraine.
- 2023Grant (prize money)$1.6M
#4
Acqui-Hired · Aarhus, Capital Region of Denmark · founded 2003 · 110 employees$44Mraised▾
Unisense FertiliTech has developed EmbryoScope Time-lapse System which allows the medical professional to follow the full embryo development without compromising the stringent culture environment required by embryos. The ability to observe embryo development in this way provides information about morphological and kinetic parameters which allows selection of embryos which are more likely to result in pregnancy.
- Mar 2013PE$20M
- Dec 2012PE$24M
#5
Series A · Aarhus, Capital Region of Denmark · founded 2018 · 16 employees$23.4Mraised▾
Developer of therapeutics for the treatment of cancer. The company has developed drugs that target intracellular protein-protein interactions of the STING pathway that increase the sensitivity of the innate immune system to detect tumour-DNA, enabling patients to prevent the further growth of tumor cells.
- Sep 2019Series A$23.4M
#6
Seed · Aarhus, Capital Region of Denmark · founded 2013 · 7 employees$4.7Mraised▾
Developer of vacuum-assisted biopsy gun for the detection of diseases Its flagship product is a handheld vacuum gun that enables physicians to take a precise core biopsy for analysis. The first application is for breast biopsies.
- Oct 2019Seed$1.9M
- May 2018Seed$870.4K
- May 2017Seed$829.7K
- Jul 2016Seed$299.3K
#7
Series A · Aarhus, Capital Region of Denmark · founded 2007 · 2 employees$2.3Mraised▾
Developer of immunoregulatory peptide therapeutics for autoimmune diseases. The company is developing STING modulators for the treatment of Systemic Lupus Erythematosus (SLE) by targeting the Stimulator of Interferon Genes (STING).
- Oct 2021Series A$1.2M
- Nov 2020Seed$827.5K
- May 2019Grant (prize money)—
- Apr 2018Seed$151.9K
#8
Series A · Aarhus, Capital Region of Denmark · founded 2001$16.8Mraised▾
Borean Pharma is focussed on developing human protein products using its proprietary technology. It three patented proprietary technologies include C-type lectin-related protein library that provides antibody mimics; trimerized tetranectin module which is a carrier for proteins, protein fragments and peptides for target ligands and protein refolding technology which enables large scale of antibody mimics in E. coli culture. It claims that its protein products will be the successors of the antibody based technology that currently constitutes the basis for the majority of the pharmaceutical protein products presently under clinical development.
- Apr 2005Series A$7.1M
- Dec 2001Series A$9.7M
#9
Funding Raised · Aarhus, Capital Region of Denmark · founded 2016 · 24 employees$43.8Kraised▾
Provider of biomarker discovery and validation. The company provides research support to clinically useful biomarkers and drug targets for treatment. It offers technology for extraction, nanostring, HTqPCR, PEA, and has application in oncology, cardiology, neurology, and exosomics.
- Jan 2020Grant (prize money)$43.8K
#10
Deadpooled · Aarhus, Capital Region of Denmark · founded 2013 · 4 employees$56.6Kraised▾
Zymonostics develops diagnostic platforms for infectious diseases. Its proprietary technology uses Rolling-circle Enhanced Enzyme Activity Detection (REEAD) that enables non-invasive, rapid diagnostics in low resource point-of-care settings. First application is malaria diagnosis, with additional applications in HIV and tuberculosis under investigation.
- Mar 2016Grant (prize money)$56.6K
#11
Seed · Aarhus, Capital Region of Denmark · founded 2019 · 6 employees$23.2Kraised▾
Developer of a rapid testing instrument designed to detect Direct Oral Anticoagulants at the point of care. The company offers a chip that can detect blood levels of the anticoagulants directly from blood samples, thereby enabling hospitals to provide an available test to use in individual departments to benefit patients.
#12
Funding Raised · Aarhus, Capital Region of Denmark · founded 2019 · 5 employees—raised▾
Developer of diagnostics platform designed for electromagnetic detection of the biomarker targets.The company's platform offers disposable biosensors for reading the analytical result as well as for analysis of drug metabolites, food and feed safety and environmental factors, thereby offering rapid and easy detection of any type of biomarker in a variety of relevant samples.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Aarhus is moving
A read on the academic research around Biotechnology in Aarhus — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 62 papers.
- Aarhus University56
- Aarhus University Hospital13
- Natural History Museum Aarhus1
- Microbiome2
- Cell2
- RNA-binding protein2
- Bacteria2
- Nucleic acid2
- Transcriptome3
- Greenhouse2
- Cell culture2
- Consumption (sociology)2
- Dairy industry2
- Food science2
- Perspective (graphical)2
- Gene2
- Selection (genetic algorithm)2
- Action (physics)1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.